Independent Director Mr. Navin Kumar retires after first term
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Navin Kumar (DIN 08778662) retires as Independent Director of Bafna Pharmaceuticals upon completion of his first term, effective close of business on June 22, 2026. He also steps down as Chairman of the Audit Committee and Nomination and Remuneration Committee. The committees have been re-constituted with Mr. Palamadai Krishnan Sundaresan as the new Chairman of both committees from June 23, 2026. The company confirms the board and its committees remain compliant with applicable laws.
Routine governance change after completion of first term. Board and committees stay compliant. No material impact expected on the stock.